Obesity
Other Therapy Areas
Explore diabetes
Explore obesity
Explore rare bleeding disorders
Explore growth-related disorders
Explore hormone replacement therapy
Medical Information | Non-US Health Care Professionals
Account Settings
Sign Out
Sign In | Create Account
  • Obesity Home
    • Products
      Obesity Treatments
    • Professional Resources
      Product Resources Library
  • Sample Requests
    • Disease Education
      Obesity: A Chronic Disease
    • Treatment Guidelines
      AACE Obesity Guidelines
    • Additional Resources
      Organizations & Conferences
    • Product Education
      Product Education Library
    • Disease Education
      Disease Education Library
    • Prescription Savings & Coverage
      Savings Cards Coverage Support
    • Support Programs
      Weight-Loss Support
  • Sign In
    Create Account
    • Account Settings
    • Sign Out
    Other Therapy Areas
    Medical Information
    Non-US Health Care Professionals

The AACE guidelines for screening, diagnosing and treating patients for obesity

Actor portrayal

Actor portrayal

The AACE guidelines for screening, diagnosing and treating patients for obesity

Actor portrayal

Actor portrayal

Obesity has been designated as a chronic disease by numerous medical associations and obesity organizations, including the American Association of Clinical Endocrinologists (AACE).1 Data from the National Health and Nutrition Examination Survey show that approximately 42% of adults in the United States have obesity.2

Logo of the American Association of Clinical Endocrinologists (AACE), representing the AACE guidelines for the screening, diagnosis, and treatment of patients with obesity

Access the guidelines

Get complete information on the potential complications of obesity and guidance on screening, diagnosing and treating patients with obesity by accessing the AACE Comprehensive Clinical Practice Guidelines For Medical Care of Patients With Obesity.

Visit website

References:

  1. Garvey W, Mechanick J, Brett E, et al. American Association of Clinical Endocrinologists and American College of Endocrinology comprehensive clinical practice guidelines for medical care of patients with obesity. Endocr Pract. 2016;22(Suppl 3):1-203.
  2. Centers for Disease Control and Prevention. Prevalence of Obesity and Severe Obesity Among Adults: United States, 2017–2018. Atlanta, GA: Centers for Disease Control and Prevention, US Dept of Health and Human Services; February, 2020
Obesity
Other Therapy Areas
Explore diabetes
Explore obesity
Explore rare bleeding disorders
Explore growth-related disorders
Explore hormone replacement therapy
  • Obesity Home
  • Product Information
    Products
    • Obesity Treatments
    Professional Resources
    • Product Resources Library
  • Sample Requests
  • Professional Education
    Disease Education
    • Obesity: A Chronic Disease
    Treatment Guidelines
    • AACE Obesity Guidelines
    Additional Resources
    • Organizations & Conferences
  • Patient Support
    Product Education
    • Product Education Library
    Disease Education
    • Disease Education Library
    Prescription Savings & Coverage
    • Savings Cards
      Coverage Support
    Support Programs
    • Weight-Loss Support

novoMEDLINK™ is a trademark of Novo Nordisk A/S.
Novo Nordisk is a registered trademark of Novo Nordisk A/S.
All other trademarks, registered or unregistered, are the property of their respective owners.
Non-US Health Care Professionals, please go to www.novonordiskpro.com.

Legal Notice | Privacy Policy | Cookie Policy | Contact Us |
novonordisk-us.com    
© 2021 Novo Nordisk All rights reserved.  US21HCP00033 May 2021

Quick links

Request medication samples

Obesity treatment guidelines

Patient savings card offer

Patient support program